The Cancer Letter: "Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data - Agency Accepts"

This article is reprinted with permission from The Cancer Letter - an award-winning weekly newsletter providing the latest on cancer research funding, legislation, policy issues, drug development and people in the news.


 

Share |

Join us in our fight for a cure!

Twitter